EnVVeno Medical Q1 EPS $(0.31) Beats $(0.40) Estimate
EnVVeno Medical Q1 EPS $(0.31) Beats $(0.40) Estimate
EnvVeno Medical第一季度每股收益美元(0.31)超過預期(0.40美元)
enVVeno Medical (NASDAQ:NVNO) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.40) by 22.5 percent. This is a 45.61 percent increase over losses of $(0.57) per share from the same period last year.
EnvVeno Medical(納斯達克股票代碼:NVNO)公佈的季度虧損爲每股0.31美元,比分析師普遍預期的0.40美元(0.40美元)高出22.5%。這比去年同期每股虧損0.57美元(0.57美元)增長了45.61%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。